Chemotherapy in combination with immunotherapy has already been used for patients with metastatic lung adenocarcinoma for over a year. A second type of non-small cell lung cancer, called squamous lung cancer, just had a similar approval for benefit of immunotherapy in combination with chemotherapy compared to chemo by itself. In the KEYNOTE-407 trial, patients with… Read more »
